We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMC icon
1276
Commercial Metals
CMC
$7.53B
-6,000
Closed -$127K
CMPR icon
1277
Cimpress
CMPR
$2.41B
-216
Closed -$31K
CMT icon
1278
Core Molding Technologies
CMT
$208M
-2,650
Closed -$38K
CNCR
1279
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
-700
Closed -$17K
CNK icon
1280
Cinemark Holdings
CNK
$3.93B
-810
Closed -$28K
CNMD icon
1281
CONMED
CNMD
$1.31B
-923
Closed -$68K
CNOB icon
1282
Center Bancorp
CNOB
$1.65B
-924
Closed -$23K
CPF icon
1283
Central Pacific Financial
CPF
$1.01B
-374
Closed -$11K
CPK icon
1284
Chesapeake Utilities
CPK
$3.26B
-1,321
Closed -$106K
CQQQ icon
1285
Invesco China Technology ETF
CQQQ
$3.08B
-360
Closed -$20K
CRS icon
1286
Carpenter Technology
CRS
$28.8B
-800
Closed -$42K
CRSP icon
1287
CRISPR Therapeutics
CRSP
$4.6B
-2,349
Closed -$138K
CRTO icon
1288
Criteo
CRTO
$1.05B
-1,016
Closed -$33K
CTAS icon
1289
Cintas
CTAS
$84.4B
-2,240
Closed -$104K
CTSO icon
1290
Cytosorbents Corp
CTSO
$22.6M
-8,662
Closed -$98K
CUBI icon
1291
Customers Bancorp
CUBI
$2.66B
-650
Closed -$18K
CUT icon
1292
Invesco MSCI Global Timber ETF
CUT
$32.4M
-675
Closed -$22K
CVGW
1293
DELISTED
Calavo Growers
CVGW
-2,327
Closed -$224K
CWI icon
1294
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.75B
-3,090
Closed -$76K
CWT icon
1295
California Water Service
CWT
$3.04B
-358
Closed -$14K
CZA icon
1296
Invesco Zacks Mid-Cap ETF
CZA
$189M
-233
Closed -$15K
C.PRN icon
1297
Citigroup Capital XIII 7.875% Fixed Rate/Floating Rate Trust Preferred Securities
C.PRN
$2.56B
-800
Closed -$22K
DAN icon
1298
Dana Inc
DAN
$2.93B
-681
Closed -$14K
DBEF icon
1299
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.18B
-3,774
Closed -$119K
DBJP icon
1300
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$691M
-3,534
Closed -$147K

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.